KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biocryst Pharmaceuticals (BCRX) Cash & Equivalents: 2009-2014

Historic Cash & Equivalents for Biocryst Pharmaceuticals (BCRX) over the last 6 years, with Dec 2014 value amounting to $54.5 million.

  • Biocryst Pharmaceuticals' Cash & Equivalents fell 61.52% to $46.6 million in Q3 2015 from the same period last year, while for Sep 2015 it was $46.6 million, marking a year-over-year decrease of 61.52%. This contributed to the annual value of $54.5 million for FY2014, which is 157.70% up from last year.
  • Per Biocryst Pharmaceuticals' latest filing, its Cash & Equivalents stood at $54.5 million for FY2014, which was up 157.70% from $21.2 million recorded in FY2013.
  • In the past 5 years, Biocryst Pharmaceuticals' Cash & Equivalents registered a high of $54.5 million during FY2014, and its lowest value of $13.6 million during FY2010.
  • Over the past 3 years, Biocryst Pharmaceuticals' median Cash & Equivalents value was $21.2 million (recorded in 2013), while the average stood at $32.2 million.
  • In the last 5 years, Biocryst Pharmaceuticals' Cash & Equivalents crashed by 66.88% in 2010 and then spiked by 157.70% in 2014.
  • Yearly analysis of 5 years shows Biocryst Pharmaceuticals' Cash & Equivalents stood at $13.6 million in 2010, then rose by 20.72% to $16.4 million in 2011, then climbed by 27.04% to $20.9 million in 2012, then rose by 1.31% to $21.2 million in 2013, then soared by 157.70% to $54.5 million in 2014.